Therapeutic angiogenesis: A new frontier for vascular therapy

Vascular Medicine

Volumn 1, Issue 1, 1996, Pages 79-87

  Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; gene transfer; growth factor; vascular endothelial

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GLYCERYL TRINITRATE; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; CONFERENCE PAPER; GENE TRANSFER; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL MODEL; ARTERIAL CIRCULATION; ARTICLE; BINDING SITE; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DISEASE COURSE; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HUMAN; INTERNAL ILIAC ARTERY; LEG ISCHEMIA; PROTEIN SECRETION; RABBIT; RECEPTOR AFFINITY;

EID: 0029975133     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9600100114     Document Type: Conference Paper

References (87)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-86.
2. Shing Y, Folkman J, Sullivan J, Butterfield R, Murray J, Klagsbrun M. Heparin-affinity purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296-99.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-34.
4. Hockel M, Schienger K, Doctrow S, Kissel T, Vaupal P. Therapeutic angiogenesis. Arch Surg 1993; 128: 423-29.
5. Baffour R, Herman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16: 181-91.
6. Pu LQ, Sniderman AD, Brassard R et al. Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 1993; 88: 208-15.
7. Yanagisawa-Miwa A, Uchida Y, Nakamura F et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257: 1401-103.
8. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-55.
9. Keck PJ, Hauser SD, Krivi G et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-42.
10. Connolly DR, Olander JV, Heuvelman D et al. Human vascular permeability factor: isolation from U937 cells. J Biol Chem 1989; 264: 20017-24.
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-309.
12. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-91.
13. Millauer B, Wizigmann-Voos S, Schnurch H et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-46.
14. Terman BI, Dougher-Vermozen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992; 187: 1579-86.
15. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217-39.
16. Reidy MA, Clowes AW, Schwartz SM. Endothelial regeneration V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest 1983; 49: 569-75.
17. Conn G, Soderman D, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA. Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc Natl Acad Sci USA 1990; 87: 1323-27.
18. Shen H, Clauss M, Ryan J et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 1993; 81: 2767-73.
19. Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.
20. Levy AP, Tamargo R, Brem H, Nathans D. An endolhelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 1989; 2: 9-19.
21. Connolly DT, Hewelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-78.
22. Takeshita S, Zheng LP, Brogi E et al. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70.
23. Takeshita S, Pu LQ, Stein LA et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90 (Part 2): II-228-II-234.
24. Bauters C, Asahara T, Zheng LP et al. Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth fasctor. J Vasc Surg 1995; 21: 314-25.
25. Bauters C, Asahara T, Zheng LP et al. Physiologic assessment of augmented vascularity induced by VEGF in rabbit ischemic hindlimb. Am J Physiol 1994; 36: H1263-H1271.
26. Sellke FW, Quillen JE, Brooks LA, Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 1990; 81: 1938-47.
27. Sellke FW, Harada K, Wang SY et al. Basic-fibroblast growth factor preserves endothelial function in the microcirculation perfused by collaterals. Abstracts of the scientific conference on the molecular cellular biology of the vascular wall, Boston, MA, October 15-17 1993 (abstract).
28. Bauters C, Asahara T, Zheng LP et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb following administration of vascular endothelial growth factor. Circulation 1995; 91: 2802-809.
29. Losordo DW, Pickering JG, Takeshita S et al. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 1994; 89: 785-92.
30. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 1993; 4: 749-58.
31. Takeshita S, Weir L, Zheng LP et al. Arterial gene transfer for therapeutic angiogenics: preclinical studies. Semin Intervent Cardiol 1996 (in press).
32. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47: 211-18.
33. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol 1987; 49: 453-64.
34. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629-32.
35. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-85.
36. Dvorak HF, Sioussat TM, Brown LF et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174: 1275-78.
37. Schaper W. Coronary collateral development: concepts and hypothesis. In: Schaper W and Schaper J, eds. Collateral circulation: heart, brain, kidney, limbs. Boston: Kluwer, 1993: 41-64.
38. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. Mechanisms of neovascularization: vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984; 51: 624-34.
39. Nicosia RF, Bonanno E, Smith M. Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 1993; 154: 654-61.
40. Schaper J, Weibrauch D. Collateral vessel development in the porcine and canine heart. In: Schaper W, Schaper J, eds. Collateral circulation: heart, brain, kidney, limbs. Boston: Kluwer, 1993: 65-102.
41. Schaper W, de Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971; 28: 671-79.
42. Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol 1982; 242: H1031-H1037.
43. Cowan DF, Hollenberg NK, Connelly CM, Williams DH, Abrams HL. Increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in the dog. Invest Radiol 1978; 13: 143-49.
44. Ilich N, Hollenberg NK, Williams DH, Abrams H. Time course of increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in rat. Circ Res 1979; 45: 579-82.
45. White FC, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992; 71: 1490-500.
46. Schaper W, Schaper J, Xhonneux R, Vandesteene R. The morphology of intercoronary anastomoses in chronic coronary artery occlusion. Cardiovasc Res 1969; 3: 315-23.
47. Graham AM, Baffour R, Burdon T et al. A demonstration of vascular proliferation in response to arteriovenous reversal in the ischemic canine hind limb. J Surg Res 1989; 47: 341-47.
48. Symes JF, Graham AM, Stein L, Sniderman AD. Salvage of a severely ischemic limb by arteriovenous revascularization: a case report. Can J Surg 1984; 27: 274-76.
49. Unger EF, Banai S, Shou M et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994; 266: H1588-H1595.
50. Takeshita S, Kearney M, Loushin C et al. In vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb. J Am Coll Cardiol 1994; 23: 294A (abstract).
51. Dvorak HF. Tumors: wound that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-59.
52. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem 1994; 269: 3076-80.
53. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 1994; 189: 824-31.
54. Ross R, Glomset B, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974; 71: 1207-10.
55. Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS. Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 1985; 316: 748-50.
56. Collins T, Pober JS, Gimbrone MA Jr, Betsholtz C, Westermark B, Heldin C-H. Cultured human endothelial cells express platelet-derived factor A chain. Am J Pathol 1987; 126: 7-12.
57. Zerwes H-G, Risau W. Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J Cell Biol 1987; 105: 2037-41.
58. Gay CG, Winkles JA. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J Biol Chem 1990; 265: 3284-92.
59. Roberts AB, Sporn MB, Assoian RK et al. Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83:4167-71.
60. Risau W, Drexler H, Mironov V et al. Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992; 7: 261-66.
61. Lindner V, Lappi DA, Baird RA, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
62. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ Res 1993; 73: 589-95.
63. Beitz JG, Kim IS, Calabresi P, Frackelton AR. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 1991; 88: 2021-25.
64. Smits A, Hermansson M, Nister M, Kamushina I, Heldin C-H, Oberg K. Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors 1989; 2: 1-8.
65. Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN. The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 1989; 124: 2021-25.
66. D'Amore P, Smith SR. Growth factor effects on cells of the vascular wall: a survey. Growth Factors 1993; 8: 61-75.
67. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TE, Fox GM, Thomason A. Platelet derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol 1992; 140: 1375-88.
68. Sims DE. The perycite - a review. Tissue Cell 1986; 18: 153-74.
69. Sundberg C, Ljungstrom M, Lindmark G, Gerdin B, Rubin K. Microvascular pericytes express platelet-derived growth factor-b receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol 1993; 143: 1377-88.
70. Sato N, Beitz JG, Kato J et al. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993; 142: 1119-39.
71. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-52.
72. Pepper MS, Vassalli JD, Orci L, Montesano R. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 1993; 204: 356-63.
73. Chen JK, Hoshi H, McKeehan WL. Transforming growth factor type β specifically stimulates synthesis of proteoglycans in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 1987; 84: 5287-91.
74. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol 1993; 106: 1375-84.
75. Winkles JA, Gay CG. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin binding (acidic and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth Differ 1991; 2: 531-40.
76. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Science 1992; 359: 843-45.
77. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266: 11947-11954.
78. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. Blood 1993; 268: 21513-18.
79. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69: 508-17.
80. Asahara T, Haulers C, Pastore CJ et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793-801.
81. Asahara T, Haulers C, Pastore CJ et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (in press).
82. Klagsbrun M, Folkman J. Angiogenesis. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors II. New York: Springer-Verlag, 1990: 459-586.
83. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993; 68: 106-13.
84. Klagsbrun M, Baird A. A duel receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229-31.
85. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269: 25646-54.
86. Isner JM, Walsh K, Symes J et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995; 91: 2687-92.
87. Fischer M, Meadows M-E, Do T et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent cerebral ischemia in rats. J Cereb Blood Flow Metab 1996 (in press).